Alteration of tobacco alkaloid content through modification of specific cytochrome P450 genes

Patent metadata

Field	Value
Publication number	US-9228195-B2
Application number	US-201213361235-A
Country	US
Kind code	B2
Filing date	Jan 30, 2012
Priority date	Nov 12, 2007
Publication date	Jan 5, 2016
Grant date	Jan 5, 2016

Abstract

Compositions and methods for reducing the level of nornicotine and N′-nitrosonornicotine (NNN) in Nicotiana plants and plant parts thereof are provided. The compositions comprise isolated polynucleotides and polypeptides for cytochrome P450s that are involved in the metabolic conversion of nicotine to nornicotine in these plants. Expression cassettes, vectors, plants, and plant parts thereof comprising inhibitory sequences that target expression or function of the disclosed cytochrome P450 polypeptides are also provided. Methods for the use of these novel sequences to inhibit expression or function of cytochrome P450 polypeptides involved in this metabolic conversion are also provided. The methods find use in the production of tobacco products that have reduced levels of nornicotine and its carcinogenic metabolite, NNN, and thus reduced carcinogenic potential for individuals consuming these tobacco products or exposed to secondary smoke derived from these products.

First claim

What is claimed is:

1. A tobacco seed, a tobacco plant grown therefrom, or a part of said tobacco plant, wherein said tobacco seed, tobacco plant grown therefrom, or part of said tobacco plant comprises a first mutation in a wild type allele encoding a nicotine demethylase having the amino acid sequence of SEQ ID NO: 2, wherein said first mutation causes a substitution at position 422 of SEQ ID NO: 2, and wherein said first mutation reduces the activity of said nicotine demethylase.

2. The tobacco seed, a tobacco plant grown therefrom, or a part of said tobacco plant, according to claim 1 , wherein said tobacco seed, tobacco plant grown therefrom, or part of said tobacco plant further comprises a second mutation in a wild type allele encoding a nicotine demethylase having the amino acid sequence of SEQ ID NO: 13, wherein said second mutation reduces the activity of said nicotine demethylase.

3. The tobacco seed, a tobacco plant grown therefrom, or a part of said tobacco plant, according to claim 1 , wherein tobacco material cured from said tobacco plant comprises a lower level of nornicotine or N′-nitrosonornicotine compared to cured tobacco material made from a tobacco plant comprising said wild type allele.

4. The tobacco seed, a tobacco plant grown therefrom, or a part of said tobacco plant, according to claim 1 , wherein the conversion of nicotine to nornicotine in tobacco material cured from said tobacco plant is selected from the group consisting of less than 0.3%, less than 0.5%, less than 0.7%, between 0.1%-0.5%, between 0.1%-0.4%, between 0.1%-0.7%, and between 0.1%-1.0%.

5. The tobacco seed, a tobacco plant grown therefrom, or a part of said tobacco plant, according to claim 1 , wherein said tobacco plant has a non-converter phenotype.

6. The tobacco seed, a tobacco plant grown therefrom, or a part of said tobacco plant, according to claim 1 , wherein said tobacco plant is a hybrid.

7. The tobacco seed, a tobacco plant grown therefrom, or a part of said tobacco plant, according to claim 1 , wherein said tobacco plant is selected from the group consisting of a Burley type, a dark type, a flue-cured type, and an Oriental type.

8. The tobacco seed, a tobacco plant grown therefrom, or a part of said tobacco plant, according to claim 1 , wherein said first mutation results in a Tryptophan to stop codon substitution at amino acid position 422, wherein said amino acid position numbering is according to SEQ ID NO:2.

9. The tobacco seed, a tobacco plant grown therefrom, or a part of said tobacco plant, according to claim 2 , wherein said first or second mutation is selected from the group consisting of a point mutation, a deletion, an insertion, and an inversion.

10. The tobacco seed, a tobacco plant grown therefrom, or a part of said tobacco plant, according to claim 2 , wherein said second mutation results in a Tryptophan to stop codon substitution at amino acid position 329, wherein said amino acid position numbering is according to SEQ ID NO:13.

11. The tobacco seed, a tobacco plant grown therefrom, or a part of said tobacco plant, according to claim 2 , wherein said tobacco plant is homozygous for said first or second mutation, or both.

12. The tobacco seed, a tobacco plant grown therefrom, or a part of said tobacco plant, according to claim 8 , wherein said second mutation results in a Tryptophan to stop codon substitution at amino acid position 329, wherein said amino acid position numbering is according to SEQ ID NO:13.

Assignees

• Dewey Ralph E
• Siminszky Balazs
• Bowen Steven W
• Gavilano Lily
• Univ North Carolina State
• Univ Kentucky Res Found

Inventors

• Dewey Ralph E
• Siminszky Balazs
• Bowen Steven W
• Gavilano Lily

Classifications

• A01H5/12

  Leaves · CPC title

• C12N9/0073 Primary

  with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13 · CPC title

• C12N15/8243 Primary

  involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine · CPC title

• A01H1/06

  Processes for producing mutations, e.g. treatment with chemicals or with radiation (specific mutations prepared by genetic engineering on plant cell or plant tissues C12N15/00 {; process for producing transgenic plants C12N15/82}) · CPC title

• A01H6/823

  Nicotiana, e.g. tobacco · CPC title